Channel Therapeutics Corp... (CHRO)
AMEX: CHRO
· Real-Time Price · USD
1.35
0.09 (7.14%)
At close: Jul 01, 2025, 3:59 PM
7.14% (1D)
Bid | 1.29 |
Market Cap | 8.9M |
Revenue (ttm) | n/a |
Net Income (ttm) | -7.36M |
EPS (ttm) | -12 |
PE Ratio (ttm) | -0.1125 |
Forward PE | n/a |
Analyst | n/a |
Ask | 1.38 |
Volume | 193,120 |
Avg. Volume (20D) | 111,305 |
Open | 1.25 |
Previous Close | 1.26 |
Day's Range | 1.23 - 1.48 |
52-Week Range | 1.23 - 54.29 |
Beta | 3.29 |
About CHRO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CHRO
Website n/a
1 month ago
+15.38%
Channel Therapeutics shares are trading higher aft...
Unlock content with
Pro Subscription
4 months ago
+47.2%
Channel Therapeutics shares are trading higher after the company announced that it will combine with Ligand Subsidiary Pelthos Therapeutics to create a pain medicines focused entity.

1 year ago · seekingalpha.com
U.S. IPO Weekly Recap: Nano-Caps Debut In Quiet WeekU.S. IPO Weekly Recap: Nano-Caps Debut In Quiet Week